NEW YORK (GenomeWeb News) – Illumina and Laboratory Corporation of America have signed a multi-year supply agreement for Illumina's next-gen sequencing instruments and microarray equipment, the companies said today.

The deal gives LabCorp expanded rights to use Illumina's instruments to develop, validate, and market laboratory-developed tests to clinicians in the US and Canada.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.